Beobachtungsplan, NIS 71: β-Confident Clinical Outcomes and Safety: A Registry Study of Ilaris® (canakinumab) Patients An open-label, long-term, prospective, observational study to monitor the safety and effectiveness of Ilaris in CAPS patients

Datei

• Artikel "Beobachtungsplan, NIS 71: β-Confident Clinical Outcomes and Safety: A Registry Study of Ilaris® (canakinumab) Patients An open-label, long-term, prospective, observational study to monitor the safety and effectiveness of Ilaris in CAPS patients"Herunterladen(PDF, 490KB, Datei ist nicht barrierefrei)